In various cancers, the anti-tumoral effect exerted by the treatment with EGCG has also been evidenced by investigating the phosphatase and tensin homolog (PTEN), a regulator of the PI3K/Akt/mTOR signaling cascade. This evidence concerns the gene AKT1 and cancer.